Novartis already sells one radioligand therapy – Lutathera (177Lu- oxodotreotide) for neuroendocrine tumours – which made $475 million last year, but Pluvicto has the potential to be a bigger ...

Novartis has several ongoing clinical trials using both Pluvicto and Lutathera that will be impacted by its manufacturing issues, according to the company. For Pluvicto that includes a pair of ...

But following talks between darts' governing body the PDC and the major TV rights holders, they were scrapped in January 2018 over sexism concerns. Superstar Michael van Gerwen was one of the top ...

Novartis is exploring a diverse portfolio of new isotopes, ligands and combination therapies to expand the use of RLTs in additional cancer types beyond prostate and neuroendocrine tumors EAST ...

Lantheus may have been hoping that “statistically significant” phase 3 data for its radioligand therapy would make a splash at ESMO, but not everyone is impressed. The biotech used the ...

On May 22, 2023, Chevron CVX announced that it had entered into a definitive agreement with PDC Energy, Inc. (NASDAQ: PDCE). Chevron will acquire all of the outstanding shares of PDC in an all ...

This dealer is operating on an appointment only basis. Welcome to the PDC Motor Group. We are a family run business and have been in the motor trade for over 15 years. From car sales to car ...

Novartis is exploring a diverse portfolio of new isotopes, ligands and combination therapies to expand the use of RLTs in additional cancer types beyond prostate and neuroendocrine tumors EAST ...